Position in CPRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$24,415,587
+$9,268,232 QoQ
Shares Held
986,090
+51.9% QoQ
Ownership
0.806%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. CPRX ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in CPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,415,587 | 986,090 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $15,147,355 | 648,987 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,694,096 | 593,609 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $18,331,660 | 844,777 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,415,547 | 759,404 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,086,045 | 722,858 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,231,357 | 212,845 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,623,866 | 169,391 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,202,237 | 389,099 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,889,200 | 469,316 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,983,027 | 340,721 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $4,805,134 | 357,525 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,427,567 | 387,670 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,979,244 | 590,282 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $4,221,620 | 329,043 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,278,333 | 325,012 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $2,607,329 | 314,515 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,961,045 | 289,667 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,347,443 | 442,914 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,280,799 | 396,661 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,576,952 | 558,992 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,100,833 | 329,591 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $819,274 | 275,850 | Shares | Defined | 2020-11-12 | |
| 2020-03-31 | $8,758 | 2,275 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||